TACE has been shown to improve survival compared with best supportive care in meta-analyses of randomized trials. HCC shows chemoresistance, thus the role of embolization might be more important ...

SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular ...

Results of CHANCE 2005/CARES-005 study were unveiled by Dr Gao-Jun Teng from Zhongda Hospital, Southeast University, China, ...

Traditionally, the best option for such patients is a procedure called transarterial chemoembolization (TACE), which shrinks the cancer by delivering chemotherapy drugs directly to the tumor and ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.